Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Effects of Antihypertensive Drugs (MEAD)
NCT00887510Phase 4Completed
- Sponsor
- University of Florida
- Start
- May 2007
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydrochlorothiazide and trandolapril in hypertension (HTN), sponsored by University of Florida. Started May 2007; status: completed.
02
Drugs
hydrochlorothiazidetrandolapril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00887510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00887510.